The spectrum of genetic mutations in myelodysplastic syndrome: Should we update prognostication?

The natural history of patients with myelodysplastic syndrome (MDS) is dependent upon the presence and magnitude of diverse genetic and molecular aberrations. The International Prognostic Scoring System (IPSS) and revised IPSS (IPSS‐R) are the most widely used classification and prognostic systems;...

Descripción completa

Detalles Bibliográficos
Autores principales: Cook, Michael R., Karp, Judith E., Lai, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176033/
https://www.ncbi.nlm.nih.gov/pubmed/35846202
http://dx.doi.org/10.1002/jha2.317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176033/
https://www.ncbi.nlm.nih.gov/pubmed/35846202
http://dx.doi.org/10.1002/jha2.317

Ejemplares similares